Invesco Ltd. - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 2 filers reported holding ACORDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$379,000
+28.5%
549,367
-4.1%
0.00%
Q3 2020$295,000
-32.2%
573,061
-3.2%
0.00%
Q2 2020$435,000
-52.6%
592,005
-39.9%
0.00%
Q1 2020$918,000
+6.4%
984,266
+132.7%
0.00%
Q4 2019$863,000
-17.4%
422,985
+16.2%
0.00%
Q3 2019$1,045,000
-59.3%
364,096
+8.9%
0.00%
-100.0%
Q2 2019$2,565,000
-52.5%
334,456
-17.7%
0.00%
-50.0%
Q1 2019$5,399,000
-77.6%
406,228
-73.7%
0.00%
-77.8%
Q4 2018$24,104,000
-19.1%
1,547,069
+2.0%
0.01%0.0%
Q3 2018$29,794,000
-20.7%
1,516,226
+15.8%
0.01%
-25.0%
Q2 2018$37,570,000
+548.4%
1,309,058
+434.4%
0.01%
+500.0%
Q1 2018$5,794,000
-79.4%
244,972
-81.3%
0.00%
-80.0%
Q4 2017$28,087,000
-6.2%
1,309,443
+3.4%
0.01%
-9.1%
Q3 2017$29,948,000
+168.7%
1,266,289
+123.8%
0.01%
+266.7%
Q2 2017$11,145,000
+30.1%
565,719
+38.7%
0.00%0.0%
Q1 2017$8,565,000
+251.7%
407,850
+215.0%
0.00%
+200.0%
Q4 2016$2,435,000
-72.3%
129,476
-69.3%
0.00%
-66.7%
Q3 2016$8,800,000
-13.4%
421,417
+5.7%
0.00%
-25.0%
Q2 2016$10,164,000
+9.4%
398,517
+13.5%
0.00%0.0%
Q1 2016$9,287,000
-52.8%
351,117
-23.7%
0.00%
-50.0%
Q4 2015$19,687,000
+30.2%
460,192
-19.3%
0.01%
+33.3%
Q3 2015$15,115,000
-27.0%
570,139
-8.2%
0.01%
-25.0%
Q2 2015$20,694,000
+9.3%
620,882
+9.1%
0.01%
+14.3%
Q1 2015$18,931,000
-2.1%
568,836
+20.2%
0.01%0.0%
Q4 2014$19,336,000
+20.6%
473,113
-0.1%
0.01%
+16.7%
Q3 2014$16,038,000
-44.1%
473,355
-44.3%
0.01%
-45.5%
Q2 2014$28,668,000
-39.6%
850,445
-32.1%
0.01%
-42.1%
Q1 2014$47,480,000
+9.1%
1,252,426
-16.0%
0.02%
+11.8%
Q4 2013$43,530,000
-14.9%
1,490,764
-0.3%
0.02%
-22.7%
Q3 2013$51,146,000
+6.0%
1,495,489
+2.3%
0.02%0.0%
Q2 2013$48,234,0001,462,0730.02%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders